510(k) K934178
K934178 is an FDA 510(k) premarket notification submitted by Neometrics, Inc. for the device "ACCUSCREEN 17-HYDROXYPROGESTERONE". The FDA issued a decision of Substantially Equivalent on March 30, 1995. The device falls under product code JLX (Radioimmunoassay, 17-Hydroxyprogesterone), a Class I device regulated under 21 CFR 862.1395. Neometrics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 30, 1995
- Date Received
- August 27, 1993
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, 17-Hydroxyprogesterone
- Device Class
- Class I
- Regulation Number
- 862.1395
- Review Panel
- CH
- Submission Type